Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins

Abstract

Obesity is a growing global health concern, with a rapid increase being observed in morbid obesity. Obesity is associated with an increased cardiovascular risk and earlier onset of cardiovascular morbidity. The growing obesity epidemic is a major source of unsustainable health costs and morbidity and mortality because of hypertension, type 2 diabetes mellitus, dyslipidemia, certain cancers and major cardiovascular diseases. Similar to obesity, hypertension is a key unfavorable health metric that has disastrous health implications: currently, hypertension is the leading contributor to global disease burden, and the direct and indirect costs of treating hypertension are exponentially higher. Poor lifestyle characteristics and health metrics often cluster together to create complex and difficult-to-treat phenotypes: excess body mass is such an example, facilitating a cascade of pathophysiological sequelae that create such as a direct obesity–hypertension link, which consequently increases cardiovascular risk. Although some significant issues regarding assessment/management of obesity remain to be addressed and the underlying mechanisms governing these disparate effects of obesity on cardiovascular disease are complex and not completely understood, a variety of factors could have a critical role. Consequently, a comprehensive and exhaustive investigation of this relationship should analyze the pathogenetic factors and pathophysiological mechanisms linking obesity to hypertension as they provide the basis for a rational therapeutic strategy in the aim to fully describe and understand the obesity–hypertension link and discuss strategies to address the potential negative consequences from the perspective of both primordial prevention and treatment for those already impacted by this condition.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Figure 1

References

  1. 1

    Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, Singh GM, Gutierrez HR, Lu Y, Bahalim AN, Farzadfar F, Riley LM, Ezzati M, Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index). National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet 2011; 377: 557–567.

    PubMed  PubMed Central  Google Scholar 

  2. 2

    Bastien M, Poirier P, Lemieux I, Després JP . Overview of epidemiology and contribution of obesity to cardiovascular disease. Prog Cardiovasc Dis 2014; 56: 369–381.

    Article  PubMed  PubMed Central  Google Scholar 

  3. 3

    Fox CS, Pencina MJ, Wilson PWF, Paynter NP, Vasan RS, D’Agostino RB . Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham Heart Study. Diabetes Care 2008; 31: 1582–1584.

    PubMed  PubMed Central  Google Scholar 

  4. 4

    Landsberg L, Aronne LJ, Beilin LJ, Burke V, Igel LI, Lloyd-Jones D, Sowers J . Obesity-related hypertension: pathogenesis, cardiovascular risk, and treatment: a position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens (Greenwich) 2013; 15: 14–33.

    CAS  Google Scholar 

  5. 5

    Abdullah A, Amin FA, Stoelwinder J, Tanamas SK, Wolfe R, Barendregt J, Peeters A . Estimating the risk of cardiovascular disease using an obese-years metric. BMJ Open 2014; 4: e005629.

    PubMed  PubMed Central  Google Scholar 

  6. 6

    Merlotti C, Morabito A, Pontiroli AE . Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies. Diabetes Obes Metab 2014; 16: 719–727.

    CAS  PubMed  PubMed Central  Google Scholar 

  7. 7

    Murray CJ, Richards MA, Newton JN, Fenton KA, Anderson HR, Atkinson C, Bennett D, Bernabé E, Blencowe H, Bourne R, Braithwaite T, Brayne C, Bruce NG, Brugha TS, Burney P, Dherani M, Dolk H, Edmond K, Ezzati M, Flaxman AD, Fleming TD, Freedman G, Gunnell D, Hay RJ, Hutchings SJ, Ohno SL, Lozano R, Lyons RA, Marcenes W, Naghavi M, Newton CR, Pearce N, Pope D, Rushton L, Salomon JA, Shibuya K, Vos T, Wang H, Williams HC, Woolf AD, Lopez AD, Davis A . UK health performance: findings of the Global Burden of Disease Study 2010. Lancet 2013; 381: 997–1020.

    PubMed  PubMed Central  Google Scholar 

  8. 8

    Falaschetti E, Mindell J, Knott C, Poulter N . Hypertension management in England: a serial cross-sectional study from 1994 to 2011. Lancet 2014; 383: 1912–1919.

    PubMed  PubMed Central  Google Scholar 

  9. 9

    Chopra I, Kamal KM, Candrilli SD . Variations in blood pressure and lipid goal attainment in primary care. Curr Med Res Opin 2013; 29: 1115–1125.

    PubMed  PubMed Central  Google Scholar 

  10. 10

    Bramlage P, Pittrow D, Wittchen HU, Kirch W, Boehler S, Lehnert H, Hoefler M, Unger T, Sharma AM . Hypertension in overweight and obese primary care patients is highly prevalent and poorly controlled. Am J Hypertens 2004; 17: 904–910.

    PubMed  PubMed Central  Google Scholar 

  11. 11

    Banegas JR, López-García E, Dallongeville J, Guallar E, Halcox JP, Borghi C, Massó-González EL, Jiménez FJ, Perk J, Steg PG, De Backer G, Rodríguez-Artalejo F . Achievement of treatment goals for primary prevention of cardiovascular disease in clinical practice across Europe: the EURIKA study. Eur Heart J 2011; 32: 2143–2152.

    PubMed  PubMed Central  Google Scholar 

  12. 12

    Zhou L, Li Y, Guo M, Wu Y, Zhao L . Relations of body weight status in early adulthood and weight changes until middle age with hypertension in the Chinese population. Hypertens Res 2016; 39: 913–918.

    Google Scholar 

  13. 13

    Wagner KH, Brath H . A global view on the development of non communicable diseases. Prev Med 2012; 54: S38–S41.

    PubMed  PubMed Central  Google Scholar 

  14. 14

    Thomas B, Gostin LO . Tackling the global NCD crisis: innovations in law and governance. J Law Med Ethics 2013; 41: 16–27.

    Google Scholar 

  15. 15

    Roura LC, Arulkumaran SS . Facing the noncommunicable disease (NCD) global epidemic—the battle of prevention starts in utero—the FIGO challenge. Best Pract Res Clin Obstet Gynaecol 2015; 29: 5–14.

    Google Scholar 

  16. 16

    Matheson GO, Klügl M, Engebretsen L, Bendiksen F, Blair SN, Börjesson M, Budgett R, Derman W, Erdener U, Ioannidis JP, Khan KM, Martinez R, Van Mechelen W, Mountjoy M, Sallis RE, Schwellnus M, Shultz R, Soligard T, Steffen K, Sundberg CJ, Weiler R, Ljungqvist A . Prevention and management of noncommunicable disease: the IOC consensus statement, Lausanne 2013. Br J Sports Med 2013; 47: 1003–1011.

    Google Scholar 

  17. 17

    Arena R, Guazzi M, Lianov L, Whitsel L, Berra K, Lavie CJ, Kaminsky L, Williams M, Hivert MF, Franklin NC, Myers J, Dengel D, Lloyd-Jones DM, Pinto FJ, Cosentino F, Halle M, Gielen S, Dendale P, Niebauer J, Pelliccia A, Giannuzzi P, Corra U, Piepoli MF, Guthrie G, Shurney D . Healthy lifestyle interventions to combat noncommunicable disease—a novel nonhierarchical connectivity model for key stakeholders: a policy statement from the American Heart Association, European Society of Cardiology, European Association for Cardiovascular Prevention and Rehabilitation, and American College of Preventive Medicine. Mayo Clin Proc 2015; 90: 1082–1103.

    Google Scholar 

  18. 18

    American Heart Association. Overweight and Obesity Statistics—2009 Update 2009.

  19. 19

    Flegal KM, Carroll MD, Ogden CL, Curtin LR . Prevalence and trends in obesity among US adults, 1999–2008. JAMA 2010; 303: 235–241.

    CAS  PubMed  PubMed Central  Google Scholar 

  20. 20

    Yang L, Colditz GA . Prevalence of overweight and obesity in the United States, 2007-2012. JAMA Intern Med 2015; 175: 1412–1413.

    PubMed  PubMed Central  Google Scholar 

  21. 21

    Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Després JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2015 update: a report from the American Heart Association. Circulation 2015; 131: e29–322.

    PubMed  PubMed Central  Google Scholar 

  22. 22

    Ng M, Fleming T, Robinson M, Thomson B, Graetz N, Margono C, Mullany EC, Biryukov S, Abbafati C, Abera SF, Abraham JP, Abu-Rmeileh NM, Achoki T, AlBuhairan FS, Alemu ZA, Alfonso R, Ali MK, Ali R, Guzman NA, Ammar W, Anwari P, Banerjee A, Barquera S, Basu S, Bennett DA, Bhutta Z, Blore J, Cabral N, Nonato IC, Chang JC, Chowdhury R, Courville KJ, Criqui MH, Cundiff DK, Dabhadkar KC, Dandona L, Davis A, Dayama A, Dharmaratne SD, Ding EL, Durrani AM, Esteghamati A, Farzadfar F, Fay DF, Feigin VL, Flaxman A, Forouzanfar MH, Goto A, Green MA, Gupta R, Hafezi-Nejad N, Hankey GJ, Harewood HC, Havmoeller R, Hay S, Hernandez L, Husseini A, Idrisov BT, Ikeda N, Islami F, Jahangir E, Jassal SK, Jee SH, Jeffreys M, Jonas JB, Kabagambe EK, Khalifa SE, Kengne AP, Khader YS, Khang YH, Kim D, Kimokoti RW, Kinge JM, Kokubo Y, Kosen S, Kwan G, Lai T, Leinsalu M, Li Y, Liang X, Liu S, Logroscino G, Lotufo PA, Lu Y, Ma J, Mainoo NK, Mensah GA, Merriman TR, Mokdad AH, Moschandreas J, Naghavi M, Naheed A, Nand D, Narayan KM, Nelson EL, Neuhouser ML, Nisar MI, Ohkubo T, Oti SO, Pedroza A, Prabhakaran D, Roy N, Sampson U, Seo H, Sepanlou SG, Shibuya K, Shiri R, Shiue I, Singh GM, Singh JA, Skirbekk V, Stapelberg NJ, Sturua L, Sykes BL, Tobias M, Tran BX, Trasande L, Toyoshima H, van de Vijver S, Vasankari TJ, Veerman JL, Velasquez-Melendez G, Vlassov VV, Vollset SE, Vos T, Wang C, Wang X, Weiderpass E, Werdecker A, Wright JL, Yang YC, Yatsuya H, Yoon J, Yoon SJ, Zhao Y, Zhou M, Zhu S, Lopez AD, Murray CJ, Gakidou E . Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2014; 384: 766–781.

    PubMed  PubMed Central  Google Scholar 

  23. 23

    Masters RK, Reither EN, Powers DA, Yang YC, Burger AE, Link BG . The impact of obesity on US mortality levels: the importance of age and cohort factors in population estimates. Am J Public Health 2013; 103: 1895–1901.

    PubMed  PubMed Central  Google Scholar 

  24. 24

    Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, Buchbinder R, Bull F, Burnett RT, Byers TE, Calabria B, Carapetis J, Carnahan E, Chafe Z, Charlson F, Chen H, Chen JS, Cheng AT, Child JC, Cohen A, Colson KE, Cowie BC, Darby S, Darling S, Davis A, Degenhardt L, Dentener F, Des Jarlais DC, Devries K, Dherani M, Ding EL, Dorsey ER, Driscoll T, Edmond K, Ali SE, Engell RE, Erwin PJ, Fahimi S, Falder G, Farzadfar F, Ferrari A, Finucane MM, Flaxman S, Fowkes FG, Freedman G, Freeman MK, Gakidou E, Ghosh S, Giovannucci E, Gmel G, Graham K, Grainger R, Grant B, Gunnell D, Gutierrez HR, Hall W, Hoek HW, Hogan A, Hosgood HD 3rd, Hoy D, Hu H, Hubbell BJ, Hutchings SJ, Ibeanusi SE, Jacklyn GL, Jasrasaria R, Jonas JB, Kan H, Kanis JA, Kassebaum N, Kawakami N, Khang YH, Khatibzadeh S, Khoo JP, Kok C, Laden F, Lalloo R, Lan Q, Lathlean T, Leasher JL, Leigh J, Li Y, Lin JK, Lipshultz SE, London S, Lozano R, Lu Y, Mak J, Malekzadeh R, Mallinger L, Marcenes W, March L, Marks R, Martin R, McGale P, McGrath J, Mehta S, Mensah GA, Merriman TR, Micha R, Michaud C, Mishra V, Mohd Hanafiah K, Mokdad AA, Morawska L, Mozaffarian D, Murphy T, Naghavi M, Neal B, Nelson PK, Nolla JM, Norman R, Olives C, Omer SB, Orchard J, Osborne R, Ostro B, Page A, Pandey KD, Parry CD, Passmore E, Patra J, Pearce N, Pelizzari PM, Petzold M, Phillips MR, Pope D, Pope CA 3rd, Powles J, Rao M, Razavi H, Rehfuess EA, Rehm JT, Ritz B, Rivara FP, Roberts T, Robinson C, Rodriguez-Portales JA, Romieu I, Room R, Rosenfeld LC, Roy A, Rushton L, Salomon JA, Sampson U, Sanchez-Riera L, Sanman E, Sapkota A, Seedat S, Shi P, Shield K, Shivakoti R, Singh GM, Sleet DA, Smith E, Smith KR, Stapelberg NJ, Steenland K, Stöckl H, Stovner LJ, Straif K, Straney L, Thurston GD, Tran JH, Van Dingenen R, van Donkelaar A, Veerman JL, Vijayakumar L, Weintraub R, Weissman MM, White RA, Whiteford H, Wiersma ST, Wilkinson JD, Williams HC, Williams W, Wilson N, Woolf AD, Yip P, Zielinski JM, Lopez AD, Murray CJ, Ezzati M, AlMazroa MA, Memish ZA . A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224–2260.

    PubMed  PubMed Central  Google Scholar 

  25. 25

    Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD, American Heart Association Strategic Planning Task Force and Statistics Committee. Defining and setting national goals for cardiovascular health promotion and disease reduction: the American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010; 121: 586–613.

    Google Scholar 

  26. 26

    Caldarone E, Lombardi M, Severi P, Leggio M . Ambient air pollution and hypertension: a relationship that strikes around the clock. Arch Clin Hypertens 2016; 1: 044–045.

    Google Scholar 

  27. 27

    Poulter NR, Prabhakaran D, Caulfield M . Hypertension. Lancet 2015; 386: 801–812.

    PubMed  PubMed Central  Google Scholar 

  28. 28

    Kotchen TA . Obesity-related hypertension: epidemiology, pathophysiology, and clinical management. Am J Hypertens 2010; 23: 1170–1178.

    CAS  Google Scholar 

  29. 29

    Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G . Mechanisms of obesity-induced hypertension. Hypertens Res 2010; 33: 386–393.

    Google Scholar 

  30. 30

    Katz DL . Perspective: obesity is not a disease. Nature. 2014; 508: S57.

    CAS  Google Scholar 

  31. 31

    Després JP . Excess visceral adipose tissue/ectopic fat the missing link in the obesity paradox? J Am Coll Cardiol 2011; 57: 1887–1889.

    Google Scholar 

  32. 32

    Nazare JA, Smith J, Borel AL, Aschner P, Barter P, Van Gaal L, Tan CE, Wittchen HU, Matsuzawa Y, Kadowaki T, Ross R, Brulle-Wohlhueter C, Alméras N, Haffner SM, Balkau B, Després JP, INSPIRE ME IAA Investigators. Usefulness of measuring both body mass index and waist circumference for the estimation of visceral adiposity and related cardiometabolic risk profile (from the INSPIRE ME IAA study). Am J Cardiol 2015; 115: 307–315.

    Google Scholar 

  33. 33

    WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 2004; 363: 157–163.

    Google Scholar 

  34. 34

    Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM . Body-mass index and mortality in Korean men and women. N Engl J Med 2006; 355: 779–787.

    CAS  Google Scholar 

  35. 35

    Gu D, He J, Duan X, Reynolds K, Wu X, Chen J, Huang G, Chen CS, Whelton PK . Body weight and mortality among men and women in China. JAMA 2006; 295: 776–783.

    CAS  Google Scholar 

  36. 36

    Zheng W, McLerran DF, Rolland B, Zhang X, Inoue M, Matsuo K, He J, Gupta PC, Ramadas K, Tsugane S, Irie F, Tamakoshi A, Gao YT, Wang R, Shu XO, Tsuji I, Kuriyama S, Tanaka H, Satoh H, Chen CJ, Yuan JM, Yoo KY, Ahsan H, Pan WH, Gu D, Pednekar MS, Sauvaget C, Sasazuki S, Sairenchi T, Yang G, Xiang YB, Nagai M, Suzuki T, Nishino Y, You SL, Koh WP, Park SK, Chen Y, Shen CY, Thornquist M, Feng Z, Kang D, Boffetta P, Potter JD . Association between body-mass index and risk of death in more than 1 million Asians. N Engl J Med 2011; 364: 719–729.

    CAS  PubMed  PubMed Central  Google Scholar 

  37. 37

    Karelis AD, Faraj M, Bastard JP, St-Pierre DH, Brochu M, Prud'homme D, Rabasa-Lhoret R . The metabolically healthy but obese individual presents a favorable inflammation profile. J Clin Endocrinol Metab 2005; 90: 4145–4150.

    CAS  Google Scholar 

  38. 38

    Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr. . The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002; 39: 578–584.

    Google Scholar 

  39. 39

    Lemieux I . Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? Arterioscler Thromb Vasc Biol 2004; 24: 795–797.

    CAS  Google Scholar 

  40. 40

    Després JP, Lemieux I . Abdominal obesity and metabolic syndrome. Nature 2006; 444: 881–887.

    Google Scholar 

  41. 41

    Després JP . Body fat distribution and risk of cardiovascular disease: an update. Circulation 2012; 126: 1301–1313.

    PubMed  PubMed Central  Google Scholar 

  42. 42

    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ . Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625–1638.

    PubMed  Google Scholar 

  43. 43

    Yusuf S, Hawken S, Ounpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai P Jr, Razak F, Sharma AM, Anand SS . INTERHEART Study Investigators. Obesity and the risk of myocardial infarction in 27,000 participants from 52 countries: a case-control study. Lancet 2005; 366: 1640–1649.

    Google Scholar 

  44. 44

    Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R, Hollenbeck A, Leitzmann MF . Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763–778.

    CAS  Google Scholar 

  45. 45

    Kannel WB, Brand N, Skinner JJ Jr, Dawber TR, McNamara PM . The relation of adiposity to blood pressure and development of hypertension. The Framingham study. Ann Intern Med 1967; 67: 48–59.

    CAS  Google Scholar 

  46. 46

    Vague J . The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr 1956; 4: 20–34.

    CAS  Google Scholar 

  47. 47

    Lapidus L, Bengtsson C, Larsson B, Pennert K, Rybo E, Sjöström L . Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed) 1984; 289: 1257–1261.

    CAS  Google Scholar 

  48. 48

    Larsson B, Svärdsudd K, Welin L, Wilhelmsen L, Björntorp P, Tibblin G . Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984; 288: 1401–1404.

    CAS  Google Scholar 

  49. 49

    Cassano PA, Segal MR, Vokonas PS, Weiss ST . Body fat distribution, blood pressure, and hypertension. A prospective cohort study of men in the normative aging study. Ann Epidemiol 1990; 1: 33–48.

    CAS  Google Scholar 

  50. 50

    Kissebah AH, Vydelingum N, Murray R, Evans DJ, Hartz AJ, Kalkhoff RK, Adams PW . Relation of body fat distribution to metabolic complications of obesity. J Clin Endocrinol Metab 1982; 54: 254–260.

    CAS  PubMed  PubMed Central  Google Scholar 

  51. 51

    Krotkiewski M, Bjorntorp P, Sjostrom L, Smith U . Impact of obesity on metabolism in men and women. Importance of regional adipose tissue distribution. J Clin Invest 1983; 72: 1150–1162.

    CAS  PubMed  PubMed Central  Google Scholar 

  52. 52

    Kalkhoff RK, Hartz AH, Rupley D, Kissebah AH, Kelber S . Relationship of body fat distribution to blood pressure, carbohydrate tolerance, and plasma lipids in healthy obese women. J Lab Clin Med 1983; 102: 621–627.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. 53

    Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, Pedrinelli R, Brandi L, Bevilacqua S . Insulin resistance in essential hypertension. N Engl J Med 1987; 317: 350–357.

    CAS  PubMed  PubMed Central  Google Scholar 

  54. 54

    Modan M, Halkin H, Almog S, Lusky A, Eshkol A, Shefi M, Shitrit A, Fuchs Z . Hyperinsulinemia. A link between hypertension obesity and glucose intolerance. J Clin Invest 1985; 75: 809–817.

    CAS  PubMed  PubMed Central  Google Scholar 

  55. 55

    Landsberg L . In: Birkenager WH, Robertson JIS, Zanchetti A (eds). Handbook of Hypertension. Hypertension in the Twentieth Century: Concepts and Achievements vol. 22. Elsevier: Amsterdam, The Netherlands. 2004, 245–261.

    Google Scholar 

  56. 56

    Reisin E, Jack AV . Obesity and hypertension: mechanisms, cardio-renal consequences, and therapeutic approaches. Med Clin North Am 2009; 93: 733–751.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. 57

    Narkiewicz K . Obesity, hypertension—the issue is more complex than we thought. Nephrol Dial Transplant 2006; 21: 264–267.

    PubMed  PubMed Central  Google Scholar 

  58. 58

    Wirix AJ, Kaspers PJ, Nauta J, Chinapaw MJ, Kist-van Holthe JE . Pathophysiology of hypertension in obese children: a systematic review. Obes Rev 2015; 16: 831–842.

    CAS  PubMed  PubMed Central  Google Scholar 

  59. 59

    Hall JE, do Carmo JM, da Silva AA, Wang Z, Hall ME . Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms. Circ Res 2015; 116: 991–1006.

    CAS  PubMed  PubMed Central  Google Scholar 

  60. 60

    Lambert EA, Straznicky NE, Dixon JB, Lambert GW . Should the sympathetic nervous system be a target to improve cardiometabolic risk in obesity? Am J Physiol Heart Circ Physiol 2015; 309: H244–H258.

    CAS  Google Scholar 

  61. 61

    Alvarez GE, Beske SD, Ballard TP, Davy KP . Sympathetic neural activation in visceral obesity. Circulation 2002; 106: 2533–2536.

    Google Scholar 

  62. 62

    Thorp AA, Schlaich MP . Relevance of sympathetic nervous system activation in obesity and metabolic syndrome. J Diabetes Res 2015; 2015: 341583.

    PubMed  PubMed Central  Google Scholar 

  63. 63

    Han SH, Quon MJ, Kim JA, Koh KK . Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 2007; 49: 531–538.

    CAS  Google Scholar 

  64. 64

    Lim S, Quon MJ, Koh KK . Modulation of adiponectin as a potential therapeutic strategy. Atherosclerosis 2014; 233: 721–728.

    CAS  Google Scholar 

  65. 65

    Matsuzawa Y, Funahashi T, Kihara S, Shimomura I . Adiponectin and metabolic syndrome. Arterioscler Thromb Vasc Biol 2004; 24: 29–33.

    CAS  Google Scholar 

  66. 66

    Koh KK, Park SM, Quon MJ . Leptin and cardiovascular disease: response to therapeutic interventions. Circulation 2008; 117: 3238–3249.

    PubMed  PubMed Central  Google Scholar 

  67. 67

    Quercioli A, Pataky Z, Montecucco F, Carballo S, Thomas A, Staub C, Di Marzo V, Vincenti G, Ambrosio G, Ratib O, Golay A, Mach F, Harsch E, Schindler TH . Coronary vasomotor control in obesity and morbid obesity: contrasting flow responses with endocannabinoids, leptin, and inflammation. JACC Cardiovasc Imaging 2012; 5: 805–815.

    Google Scholar 

  68. 68

    Kennedy A, Gettys TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT . The metabolic significance of leptin in humans: gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Clin Endocrinol Metab 1997; 82: 1293–1300.

    CAS  Google Scholar 

  69. 69

    Tang-Christensen M, Havel PJ, Jacobs RR, Larsen PJ, Cameron JL . Central administration of leptin inhibits food intake and activates the sympathetic nervous system in rhesus macaques. J Clin Endocrinol Metab 1999; 84: 711–717.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. 70

    Haynes WG, Morgan DA, Walsh SA, Mark AL, Sivitz WI . Receptor-mediated regional sympathetic nerve activation by leptin. J Clin Invest 1997; 100: 270–278.

    CAS  PubMed  PubMed Central  Google Scholar 

  71. 71

    Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L . Effect of insulin and glucose infusions on sympathetic nervous system activity in normal man. Diabetes 1981; 30: 219–225.

    CAS  PubMed  PubMed Central  Google Scholar 

  72. 72

    Hausberg M, Mark AL, Hoffman RP, Sinkey CA, Anderson EA . Dissociation of sympathoexcitatory and vasodilator actions of modestly elevated plasma insulin levels. J Hypertens 1995; 13: 1015–1021.

    CAS  PubMed  PubMed Central  Google Scholar 

  73. 73

    Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L . Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991; 17: 669–677.

    CAS  PubMed  PubMed Central  Google Scholar 

  74. 74

    Grassi G, Seravalle G, Cattaneo BM, Bolla GB, Lanfranchi A, Colombo M, Giannattasio C, Brunani A, Cavagnini F, Mancia G . Sympathetic activation in obese normotensive subjects. Hypertension 1995; 25: 560–563.

    CAS  Google Scholar 

  75. 75

    Scherrer U, Randin D, Tappy L, Vollenweider P, Jéquier E, Nicod P . Body fat and sympathetic nerve activity in healthy subjects. Circulation 1994; 89: 2634–2640.

    CAS  PubMed  PubMed Central  Google Scholar 

  76. 76

    Grassi G, Seravalle G, Colombo M, Bolla G, Cattaneo BM, Cavagnini F, Mancia G . Body weight reduction, sympathetic nerve traffic, and arterial baroreflex in obese normotensive humans. Circulation 1998; 97: 2037–2042.

    CAS  PubMed  PubMed Central  Google Scholar 

  77. 77

    DeFronzo RA . Insulin and renal sodium handling: clinical implications. Int J Obes 1981; 5 (Suppl 1): 93–104.

    PubMed  PubMed Central  Google Scholar 

  78. 78

    Heyman E, Gamelin FX, Aucouturier J, Di Marzo V . The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity. Obes Rev 2012; 13: 1110–1124.

    CAS  Google Scholar 

  79. 79

    Di Marzo V, Côté M, Matias I, Lemieux I, Arsenault BJ, Cartier A, Piscitelli F, Petrosino S, Alméras N, Després JP . Changes in plasma endocannabinoid levels in viscerally obese men following a 1 year lifestyle modification programme and waist circumference reduction: associations with changes in metabolic risk factors. Diabetologia 2009; 52: 213–217.

    CAS  Google Scholar 

  80. 80

    Naguib MT . Kidney disease in the obese patient. South Med J 2014; 107: 481–485.

    PubMed  PubMed Central  Google Scholar 

  81. 81

    Snyder S, Turner GA, Turner A . Obesity-related kidney disease. Prim Care 2014; 41: 875–893.

    PubMed  PubMed Central  Google Scholar 

  82. 82

    Ahmed SB, Fisher ND, Stevanovic R, Hollenberg NK . Body mass index and angiotensin-dependent control of the renal circulation in healthy humans. Hypertension 2005; 46: 1316–1320.

    CAS  PubMed  PubMed Central  Google Scholar 

  83. 83

    Hall JE, Guyton AC, Coleman TG, Mizelle HL, Woods LL . Regulation of arterial pressure: role of pressure natriuresis and diuresis. Fed Proc 1986; 45: 2897–2903.

    CAS  PubMed  PubMed Central  Google Scholar 

  84. 84

    Rocchini AP, Key J, Bondie D, Chico R, Moorehead C, Katch V, Martin M . The effect of weight loss on the sensitivity of blood pressure to sodium in obese adolescents. N Engl J Med 1989; 321: 580–585.

    CAS  PubMed  PubMed Central  Google Scholar 

  85. 85

    Goodfriend TL . Obesity, sleep apnea, aldosterone, and hypertension. Curr Hypertens Rep 2008; 10: 222–226.

    CAS  PubMed  PubMed Central  Google Scholar 

  86. 86

    Sarzani R, Salvi F, Dessi-Fulgheri P, Rappelli A . Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008; 26: 831–843.

    CAS  PubMed  PubMed Central  Google Scholar 

  87. 87

    Bomback AS, Klemmer PJ . Interaction of aldosterone and extracellular volume in the pathogenesis of obesity-associated kidney disease: a narrative review. Am J Nephrol 2009; 30: 140–146.

    CAS  PubMed  PubMed Central  Google Scholar 

  88. 88

    Frigolet ME, Torres N, Tovar AR . The renin-angiotensin system in adipose tissue and its metabolic consequences during obesity. J Nutr Biochem 2013; 24: 2003–2015.

    CAS  PubMed  PubMed Central  Google Scholar 

  89. 89

    Adamczak M, Wiecek A, Funahashi T, Chudek J, Kokot F, Matsuzawa Y . Decreased plasma adiponectin concentration in patients with essential hypertension. Am J Hypertens 2003; 16: 72–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  90. 90

    Van Cauter SK . Sleep as a mediator of the relationship between socioeconomic status and health: a hypothesis. Ann NY Acad Sci 1999; 896: 254–261.

    CAS  PubMed  PubMed Central  Google Scholar 

  91. 91

    Narkiewicz K, Somers VK . Sympathetic nerve activity in obstructive sleep apnoea. Acta Physiol Scand 2003; 177: 385–390.

    CAS  PubMed  PubMed Central  Google Scholar 

  92. 92

    Wolk R, Shamsuzzaman AS, Somers VK . Obesity, sleep apnea, and hypertension. Hypertension 2003; 42: 1067–1074.

    CAS  PubMed  PubMed Central  Google Scholar 

  93. 93

    Spiegel K, Leproult R, L'hermite-Balériaux M, Copinschi G, Penev PD, Van Cauter E . Leptin levels are dependent on sleep duration: relationships with sympathovagal balance, carbohydrate regulation, cortisol, and thyrotropin. J Clin Endocrinol Metab 2004; 89: 5762–5771.

    CAS  PubMed  PubMed Central  Google Scholar 

  94. 94

    Barker DJ . Fetal programming of coronary heart disease. Trends Endocrinol Metab 2002; 13: 364–368.

    CAS  PubMed  PubMed Central  Google Scholar 

  95. 95

    Silverman BL, Landsberg L, Metzger BE . Fetal hyperinsulinism in offspring of diabetic mothers. Association with the subsequent development of childhood obesity. Ann NY Acad Sci 1993; 699: 36–45.

    CAS  PubMed  PubMed Central  Google Scholar 

  96. 96

    Hausberg M, Barenbrock M, Kosch M . Elevated sympathetic nerve activity: the link between low birth size and adult-onset metabolic syndrome? J Hypertens 2004; 22: 1087–1089.

    CAS  PubMed  PubMed Central  Google Scholar 

  97. 97

    Caballero AE . Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 2003; 11: 1278–1289.

    CAS  PubMed  PubMed Central  Google Scholar 

  98. 98

    Barrett EJ, Eggleston EM, Inyard AC, Wang H, Li G, Chai W, Liu Z . The vascular actions of insulin control its delivery to muscle and regulate the rate-limiting step in skeletal muscle insulin action. Diabetologia 2009; 52: 752–764.

    CAS  PubMed  PubMed Central  Google Scholar 

  99. 99

    Kappus RM, Fahs CA, Smith D, Horn GP, Agiovlasitis S, Rossow L, Jae SY, Heffernan KS, Fernhall B . Obesity and overweight associated with increased carotid diameter and decreased arterial function in young otherwise healthy men. Am J Hypertens 2014; 27: 628–634.

    PubMed  PubMed Central  Google Scholar 

  100. 100

    Wofford MR, Smith G, Minor DS . The treatment of hypertension in obese patients. Curr Hypertens Rep 2008; 10: 143–150.

    CAS  Google Scholar 

  101. 101

    Colosia AD, Palencia R, Khan S . Prevalence of hypertension and obesity in patients with type 2 diabetes mellitus in observational studies: a systematic literature review. Diabetes Metab Syndr Obes 2013; 6: 327–338.

    PubMed  PubMed Central  Google Scholar 

  102. 102

    Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, Brown TM, Carnethon MR, Dai S, de Simone G, Ford ES, Fox CS, Fullerton HJ, Gillespie C, Greenlund KJ, Hailpern SM, Heit JA, Ho PM, Howard VJ, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Makuc DM, Marcus GM, Marelli A, Matchar DB, McDermott MM, Meigs JB, Moy CS, Mozaffarian D, Mussolino ME, Nichol G, Paynter NP, Rosamond WD, Sorlie PD, Stafford RS, Turan TN, Turner MB, Wong ND, Wylie-Rosett J, American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics—2011 update: a report from the American Heart Association. Circulation 2011; 123: e18–e209.

    Google Scholar 

  103. 103

    Wang Y, Wang QJ . The prevalence of prehypertension and hypertension among US adults according to the new Joint National Committee guidelines. Arch Intern Med 2004; 164: 2126–2134.

    Google Scholar 

  104. 104

    Wilson PW, D'Agostino RB, Sullivan L, Parise H, Kannel WB . Overweight and obesity as determinants of cardiovascular risk: the Framingham experience. Arch Intern Med 2002; 162: 1867–1872.

    Google Scholar 

  105. 105

    Burt VL, Whelton P, Roccella EJ, Brown C, Cutler JA, Higgins M, Horan MJ, Labarthe D . Prevalence of hypertension in the US adult population. Results from the Third National Health and Nutrition Examination Survey, 1988-1991. Hypertension 1995; 25: 305–313.

    CAS  Google Scholar 

  106. 106

    Franklin SS, Gustin W 4th, Wong ND, Larson MG, Weber MA, Kannel WB, Levy D . Hemodynamic patterns of age-related changes in blood pressure. The Framingham Heart Study. Circulation 1997; 96: 308–315.

    CAS  Google Scholar 

  107. 107

    Lloyd-Jones DM, Liu K, Colangelo LA, Yan LL, Klein L, Loria CM, Lewis CE, Savage P . Consistently stable or decreased body mass index in young adulthood and longitudinal changes in metabolic syndrome components: the Coronary Artery Risk Development in Young Adults Study. Circulation 2007; 115: 1004–1011.

    Google Scholar 

  108. 108

    Mamun AA, Lawlor DA, O'Callaghan MJ, Williams GM, Najman JM . Effect of body mass index changes between ages 5 and 14 on blood pressure at age 14: findings from a birth cohort study. Hypertension 2005; 45: 1083–1087.

    CAS  Google Scholar 

  109. 109

    Leggio M, Cruciani G, Sgorbini L, Mazza A, Bendini MG, Pugliese M, Leggio F, Jesi AP . Obesity-related adjunctive systo-diastolic ventricular dysfunction in patients with hypertension: echocardiographic assessment with tissue Doppler velocity and strain imaging. Hypertens Res 2011; 34: 468–473.

    Google Scholar 

  110. 110

    Stamler J, Dyer AR, Shekelle RB, Neaton J, Stamler R . Relationship of baseline major risk factors to coronary and all-cause mortality, and to longevity: findings from long-term follow-up of Chicago cohorts. Cardiology 1993; 82: 191–222.

    CAS  Google Scholar 

  111. 111

    Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M . Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998; 339: 229–234.

    CAS  Google Scholar 

  112. 112

    Juutilainen A, Lehto S, Rönnemaa T, Pyörälä K, Laakso M . Type 2 diabetes as a ‘coronary heart disease equivalent’: an 18-year prospective population-based study in Finnish subjects. Diabetes Care 2005; 28: 2901–2907.

    Google Scholar 

  113. 113

    Stefan N, Kantartzis K, Machann J, Schick F, Thamer C, Rittig K, Balletshofer B, Machicao F, Fritsche A, Häring HU . Identification and characterization of metabolically benign obesity in humans. Arch Intern Med 2008; 168: 1609–1616.

    Google Scholar 

  114. 114

    Aguilar-Salinas CA, García EG, Robles L, Riaño D, Ruiz-Gomez DG, García-Ulloa AC, Melgarejo MA, Zamora M, Guillen-Pineda LE, Mehta R, Canizales-Quinteros S, Tusie Luna MT, Gómez-Pérez FJ . High adiponectin concentrations are associated with the metabolically healthy obese phenotype. J Clin Endocrinol Metab 2008; 93: 4075–4079.

    CAS  Google Scholar 

  115. 115

    Meigs JB, Wilson PW, Fox CS, Vasan RS, Nathan DM, Sullivan LM, D’Agostino RB . Body mass index, metabolic syndrome, and risk of type 2 diabetes or cardiovascular disease. J Clin Endocrinol Metab 2006; 91: 2906–2912.

    CAS  Google Scholar 

  116. 116

    Karelis AD, Messier V, Brochu M, Rabasa-Lhoret R . Metabolically healthy but obese women: effect of an energy-restricted diet. Diabetologia 2008; 51: 1752–1754.

    CAS  Google Scholar 

  117. 117

    Arnlöv J, Ingelsson E, Sundström J, Lind L . Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation 2010; 121: 230–236.

    Google Scholar 

  118. 118

    Khan UI, Wang D, Thurston RC, Sowers M, Sutton-Tyrrell K, Matthews KA, Barinas-Mitchell E, Wildman RP . Burden of subclinical cardiovascular disease in ‘metabolically benign’ and ‘at-risk’ overweight and obese women: the Study of Women’s Health Across the Nation (SWAN). Atherosclerosis 2011; 217: 179–186.

    CAS  PubMed  PubMed Central  Google Scholar 

  119. 119

    Chang Y, Kim BK, Yun KE, Cho J, Zhang Y, Rampal S, Zhao D, Jung HS, Choi Y, Ahn J, Lima JA, Shin H, Guallar E, Ryu S . Metabolically-healthy obesity and coronary artery calcification. J Am Coll Cardiol 2014; 63: 2679–2686.

    Google Scholar 

  120. 120

    Park J, Kim SH, Cho GY, Baik I, Kim NH, Lim HE, Kim EJ, Park CG, Lim SY, Kim YH, Kim H, Lee SK, Shin C . Obesity phenotype and cardiovascular changes. J Hypertens 2011; 29: 1765–1772.

    CAS  Google Scholar 

  121. 121

    Lind L, Siegbahn A, Ingelsson E, Sundström J, Arnlöv J . A detailed cardiovascular characterization of obesity without the metabolic syndrome. Arterioscler Thromb Vasc Biol 2011; 31: e27–e34.

    CAS  Google Scholar 

  122. 122

    Hinnouho GM, Czernichow S, Dugravot A, Batty GD, Kivimaki M, Singh-Manoux A . Metabolically healthy obesity and risk of mortality: does the definition of metabolic health matter? Diabetes Care 2013; 36: 2294–2300.

    CAS  PubMed  PubMed Central  Google Scholar 

  123. 123

    Wildman RP, Muntner P, Reynolds K, McGinn AP, Rajpathak S, Wylie-Rosett J, Sowers MR . The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999–2004). Arch Intern Med 2008; 168: 1617–1624.

    Google Scholar 

  124. 124

    Velho S, Paccaud F, Waeber G, Vollenweider P, Marques-Vidal P . Metabolically healthy obesity: different prevalences using different criteria. Eur J Clin Nutr 2010; 64: 1043–1051.

    CAS  Google Scholar 

  125. 125

    Lee SK, Kim SH, Cho GY, Baik I, Lim HE, Park CG, Lee JB, Kim YH, Lim SY, Kim H, Shin C . Obesity phenotype and incident hypertension: a prospective community-based cohort study. J Hypertens 2013; 31: 145–151.

    CAS  Google Scholar 

  126. 126

    Kramer CK, Zinman B, Retnakaran R . Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis. Ann Intern Med 2013; 159: 758–769.

    Google Scholar 

  127. 127

    Fan J, Song Y, Chen Y, Hui R, Zhang W . Combined effect of obesity and cardiometabolic abnormality on the risk of cardiovascular disease: a meta-analysis of prospective cohort studies. Int J Cardiol 2013; 168: 4761–4768.

    PubMed  PubMed Central  Google Scholar 

  128. 128

    Puri R . Is it finally time to dispel the concept of metabolically-healthy obesity? J Am Coll Cardiol 2014; 63: 2687–2688.

    Google Scholar 

  129. 129

    Ortega FB, Lee DC, Katzmarzyk PT, Ruiz JR, Sui X, Church TS, Blair SN . The intriguing metabolically healthy but obese phenotype: cardiovascular prognosis and role of fitness. Eur Heart J 2013; 34: 389–397.

    Google Scholar 

  130. 130

    Arsenault BJ, Lachance D, Lemieux I, Alméras N, Tremblay A, Bouchard C, Pérusse L, Després JP . Visceral adipose tissue accumulation, cardiorespiratory fitness, and features of the metabolic syndrome. Arch Intern Med 2007; 167: 1518–1525.

    CAS  Google Scholar 

  131. 131

    Després JP . Obesity and cardiovascular disease: weight loss is not the only target. Can J Cardiol 2015; 31: 216–222.

    Google Scholar 

  132. 132

    Uretsky S, Messerli FH, Bangalore S, Champion A, Cooper-Dehoff RM, Zhou Q, Pepine CJ . Obesity paradox in patients with hypertension and coronary artery disease. Am J Med 2007; 120: 863–870.

    Google Scholar 

  133. 133

    Wassertheil-Smoller S, Fann C, Allman RM, Black HR, Camel GH, Davis B, Masaki K, Pressel S, Prineas RJ, Stamler J, Vogt TM . Relation of low body mass to death and stroke in the systolic hypertension in the elderly program. The SHEP Cooperative Research Group. Arch Intern Med 2000; 160: 494–500.

    CAS  Google Scholar 

  134. 134

    Lavie CJ, Milani RV, Ventura HO . Obesity, heart disease, and favorable prognosis—truth or paradox? Am J Med 2007; 120: 825–826.

    Google Scholar 

  135. 135

    von Haehling S, Doehner W, Anker SD . Revisiting the obesity paradox in heart failure: new insights? Eur J Heart Fail 2011; 13: 130–132.

    Google Scholar 

  136. 136

    Flegal KM, Kit BK, Orpana H, Graubard BI . Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis. JAMA 2013; 309: 71–82.

    CAS  PubMed  PubMed Central  Google Scholar 

  137. 137

    Shah RV, Abbasi SA, Yamal JM, Davis BR, Barzilay J, Einhorn PT, Goldfine AB, ALLHAT Collaborative Research Group. Impaired fasting glucose and body mass index as determinants of mortality in ALLHAT: is the obesity paradox real? J Clin Hypertens (Greenwich) 2014; 16: 451–458.

    Google Scholar 

  138. 138

    Lavie CJ, De Schutter A, Milani RV . Healthy obese versus unhealthy lean: the obesity paradox. Nat Rev Endocrinol 2015; 11: 55–62.

    Google Scholar 

  139. 139

    Khalid U, Ather S, Bavishi C, Chan W, Loehr LR, Wruck LM, Rosamond WD, Chang PP, Coresh J, Virani SS, Nambi V, Bozkurt B, Ballantyne CM, Deswal A . Premorbid body mass index and mortality after incident heart failure: the ARIC Study. J Am Coll Cardiol 2014; 64: 2743–2749.

    PubMed  PubMed Central  Google Scholar 

  140. 140

    Hansen BC, Bray GA . The Metabolic Syndrome Epidemiology, Clinical Treatment, and Underlying Mechanisms. Humana Press: Totowa, NJ, USA. 2008.

    Google Scholar 

  141. 141

    Reaven GM . In: Hansen BC, Bray GA eds. The Metabolic Syndrome Epidemiology, Clinical Treatment, and Underlying Mechanisms. Humana Press: Totowa, NJ, USA. 2008, 11–36.

    Google Scholar 

  142. 142

    Ervin R . Prevalence of metabolic syndrome among adults 20 years of age and over, by sex, age, race and ethnicity, and body mass index: United States, 2003–2006. Natl Health Stat Rep 2009; 13: 1–8.

    Google Scholar 

  143. 143

    Grundy SM, Brewer HB Jr, Cleeman JI, Smith SC Jr, Lenfant C, American Heart Association National Heart, Lung, and Blood Institute. Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004; 109: 433–438.

    Google Scholar 

  144. 144

    Sánchez-Lozada LG, Tapia E, Jiménez A, Bautista P, Cristóbal M, Nepomuceno T, Soto V, Avila-Casado C, Nakagawa T, Johnson RJ, Herrera-Acosta J, Franco M . Fructose-induced metabolic syndrome is associated with glomerular hypertension and renal microvascular damage in rats. Am J Physiol Renal Physiol 2007; 292: F423–F429.

    Google Scholar 

  145. 145

    Lee JE, Kim YG, Choi YH, Huh W, Kim DJ, Oh HY . Serum uric acid is associated with microalbuminuria in prehypertension. Hypertension 2006; 47: 962–967.

    CAS  Google Scholar 

  146. 146

    Johnson RJ, Segal MS, Sautin Y, Nakagawa T, Feig DI, Kang DH, Gersch MS, Benner S, Sánchez-Lozada LG . Potential role of sugar (fructose) in the epidemic of hypertension, obesity and the metabolic syndrome, diabetes, kidney disease, and cardiovascular disease. Am J Clin Nutr 2007; 86: 899–906.

    CAS  PubMed  Google Scholar 

  147. 147

    Choi J . Sugar-sweetened soft drinks, diet soft drinks, and serum uric acid level: the Third National Health and Nutrition Examination Survey. Arthritis Rheum 2008; 59: 109–116.

    CAS  Google Scholar 

  148. 148

    Spiegel K, Leproult R, Van Cauter E . Impact of sleep debt on metabolic and endocrine function. Lancet 1999; 354: 1435–1439.

    CAS  Google Scholar 

  149. 149

    Bass J, Turek FW . Sleepless in America: a pathway to obesity and the metabolic syndrome? Arch Intern Med 2005; 165: 15–16.

    Google Scholar 

  150. 150

    Turek FW, Joshu C, Kohsaka A, Lin E, Ivanova G, McDearmon E, Laposky A, Losee-Olson S, Easton A, Jensen DR, Eckel RH, Takahashi JS, Bass J . Obesity and metabolic syndrome in circadian Clock mutant mice. Science 2005; 308: 1043–1045.

    CAS  PubMed  PubMed Central  Google Scholar 

  151. 151

    Nedeltcheva AV, Kilkus JM, Imperial J, Schoeller DA, Penev PD . Insufficient sleep undermines dietary efforts to reduce adiposity. Ann Intern Med 2010; 153: 435–441.

    PubMed  PubMed Central  Google Scholar 

  152. 152

    Egan BM, Li J, Hutchison FN, Ferdinand KC . Hypertension in the United States, 1999 to 2012: progress toward Healthy People 2020 goals. Circulation 2014; 130: 1692–1699.

    PubMed  PubMed Central  Google Scholar 

  153. 153

    Borlaug BA . The pathophysiology of heart failure with preserved ejection fraction. Nat Rev Cardiol 2014; 11: 507–515.

    CAS  Google Scholar 

  154. 154

    Peng J, Zhao Y, Zhang H, Liu Z, Wang Z, Tang M, Zhong M, Lu F, Zhang W . Prevention of metabolic disorders with telmisartan and indapamide in a Chinese population with high-normal blood pressure. Hypertens Res 2015; 38: 123–131.

    CAS  Google Scholar 

  155. 155

    Janghorbani M, Bonnet F, Amini M . Glucose and the risk of hypertension in first-degree relatives of patients with type 2 diabetes. Hypertens Res 2015; 38: 349–354.

    CAS  Google Scholar 

  156. 156

    Fujii M, Ohnishi H, Saitoh S, Akasaka H, Miura T, Mori M . The combination of abdominal obesity and high-sensitivity C-reactive protein predicts new-onset hypertension in the general Japanese population: the Tanno-Sobetsu study. Hypertens Res 2015; 38: 426–432.

    CAS  Google Scholar 

  157. 157

    Nagai M, Ohkubo T, Murakami Y, Takashima N, Kadota A, Miyagawa N, Saito Y, Nishi N, Okuda N, Kiyohara Y, Nakagawa H, Nakamura Y, Fujiyoshi A, Abbott RD, Okamura T, Okayama A, Ueshima H, Miura K, NIPPON DATA80/90/2010 Research Group. Secular trends of the impact of overweight and obesity on hypertension in Japan, 1980-2010. Hypertens Res 2015; 38: 790–795.

    Google Scholar 

  158. 158

    Chen SC, Lee WH, Hsu PC, Huang JC, Lee CS, Lin TH, Voon WC, Lai WT, Sheu SH, Su HM . Association of body mass index and left ventricular mass index with abnormally low and high ankle-brachial indices in chronic kidney disease. Hypertens Res 2016; 39: 166–170.

    Google Scholar 

  159. 159

    Hirata C, Miyai N, Idoue A, Utsumi M, Hattori S, Iwahara A, Uematsu Y, Shiba M, Arita M . Effect of metabolic syndrome components and their clustering on carotid atherosclerosis in a sample of the general Japanese population. Hypertens Res 2016; 39: 362–366.

    Google Scholar 

  160. 160

    Dimitriadis K, Tsioufis C, Mazaraki A, Liatakis I, Koutra E, Kordalis A, Kasiakogias A, Flessas D, Tentolouris N, Tousoulis D . Waist circumference compared with other obesity parameters as determinants of coronary artery disease in essential hypertension: a 6-year follow-up study. Hypertens Res 2016; 39: 475–479.

    CAS  Google Scholar 

  161. 161

    Ye C, Pan Y, Xu X, Su S, Snieder H, Treiber F, Kapuku G, Wang X . Pulse wave velocity in elastic and muscular arteries: tracking stability and association with anthropometric and hemodynamic measurements. Hypertens Res 2016; 39: 786–791.

    PubMed  PubMed Central  Google Scholar 

  162. 162

    l’Allemand-Jander D . Clinical diagnosis of metabolic and cardiovascular risks in overweight children: early development of chronic diseases in the obese child. Int J Obes (Lond) 2010; 34: S32–S36.

    Google Scholar 

  163. 163

    Srinivasan SR, Myers L, Berenson GS . Changes in metabolic syndrome variables since childhood in prehypertensive and hypertensive subjects: the Bogalusa Heart Study. Hypertension 2006; 48: 33–39.

    CAS  Google Scholar 

  164. 164

    Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, Srinivasan SR, Daniels SR, Davis PH, Chen W, Sun C, Cheung M, Viikari JS, Dwyer T, Raitakari OT . Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J Med 2011; 365: 1876–1885.

    CAS  PubMed  PubMed Central  Google Scholar 

  165. 165

    Craigie AM, Lake AA, Kelly SA, Adamson AJ, Mathers JC . Tracking of obesity-related behaviours from childhood to adulthood: a systematic review. Maturitas 2011; 70: 266–284.

    Google Scholar 

  166. 166

    Eriksson J, Forsén T, Tuomilehto J, Osmond C, Barker D . Fetal and childhood growth and hypertension in adult life. Hypertension 2000; 36: 790–794.

    CAS  Google Scholar 

  167. 167

    Huang RC, Mori TA, Burke V, Newnham J, Stanley FJ, Landau LI, Kendall GE, Oddy WH, Beilin LJ . Synergy between adiposity, insulin resistance, metabolic risk factors, and inflammation in adolescents. Diabetes Care 2009; 32: 695–701.

    CAS  PubMed  PubMed Central  Google Scholar 

  168. 168

    Huang RC, Burke V, Newnham JP, Stanley FJ, Kendall GE, Landau LI, Oddy WH, Blake KV, Palmer LJ, Beilin LJ . Perinatal and childhood origins of cardiovascular disease. Int J Obes (Lond) 2007; 31: 236–244.

    CAS  Google Scholar 

  169. 169

    Chivers P, Hands B, Parker H, Beilin L, Kendall G, Bulsara M . Longitudinal modelling of body mass index from birth to 14 years. Obes Facts 2009; 2: 302–310.

    Google Scholar 

  170. 170

    Waters E, de Silva-Sanigorski A, Hall BJ, Brown T, Campbell KJ, Gao Y, Armstrong R, Prosser L, Summerbell CD . Interventions for preventing obesity in children. Cochrane Database Syst Rev 2011; (12 CD001871.

  171. 171

    Vandongen R, Jenner DA, Thompson C, Taggart AC, Spickett EE, Burke V, Beilin LJ, Milligan RA, Dunbar DL . A controlled evaluation of a fitness and nutrition intervention program on cardiovascular health in 10- to 12-year-old children. Prev Med 1995; 24: 9–22.

    CAS  Google Scholar 

  172. 172

    Burke V, Milligan RA, Thompson C, Taggart AC, Dunbar DL, Spencer MJ, Medland A, Gracey MP, Vandongen R, Beilin LJ . A controlled trial of health promotion programs in 11-year-olds using physical activity ‘enrichment’ for higher risk children. J Pediatr 1998; 132: 840–848.

    CAS  Google Scholar 

  173. 173

    Milligan RA, Thompson C, Vandongen R, Beilin LJ, Burke V . Clustering of cardiovascular risk factors in Australian adolescents: association with dietary excesses and deficiencies. J Cardiovasc Risk 1995; 2: 515–523.

    CAS  Google Scholar 

  174. 174

    Taylor BJ, Heath AL, Galland BC, Gray AR, Lawrence JA, Sayers RM, Dale K, Coppell KJ, Taylor RW . Prevention of Overweight in Infancy (POI.nz) study: a randomised controlled trial of sleep, food and activity interventions for preventing overweight from birth. BMC Public Health 2011; 11: 942.

    PubMed  PubMed Central  Google Scholar 

  175. 175

    Berenson GS . Cardiovascular health promotion for children: a model for a Parish (County)-wide program (implementation and preliminary results). Prev Cardiol 2010; 13: 23–28.

    PubMed  PubMed Central  Google Scholar 

  176. 176

    Sobko T, Svensson V, Ek A, Ekstedt M, Karlsson H, Johansson E, Cao Y, Hagströmer M, Marcus C . A randomised controlled trial for overweight and obese parents to prevent childhood obesity—Early STOPP (STockholm Obesity Prevention Program). BMC Public Health 2011; 11: 336.

    PubMed  PubMed Central  Google Scholar 

  177. 177

    Christie D, Hudson L, Mathiot A, Cole TJ, Karlsen S, Kessel A, Kinra S, Morris S, Nazareth I, Sovio U, Wong IC, Viner RM . Assessing the efficacy of the Healthy Eating and Lifestyle Programme (HELP) compared with enhanced standard care of the obese adolescent in the community: study protocol for a randomized controlled trial. Trials 2011; 12: 242.

    PubMed  PubMed Central  Google Scholar 

  178. 178

    Borys JM, Le Bodo Y, Jebb SA, Seidell JC, Summerbell C, Richard D, De Henauw S, Moreno LA, Romon M, Visscher TL, Raffin S, Swinburn B, EEN Study Group. EPODE approach for childhood obesity prevention: methods, progress and international development. Obes Rev 2012; 13: 299–315.

    PubMed  PubMed Central  Google Scholar 

  179. 179

    Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB . Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med 2011; 364: 2392–2404.

    CAS  PubMed  PubMed Central  Google Scholar 

  180. 180

    Wang Y, Beydoun MA . The obesity epidemic in the United States—gender, age, socioeconomic, racial/ethnic, and geographic characteristics: a systematic review and meta-regression analysis. Epidemiol Rev 2007; 29: 6–28.

    CAS  PubMed  PubMed Central  Google Scholar 

  181. 181

    Popkin BM, Adair LS, Ng SW . Global nutrition transition and the pandemic of obesity in developing countries. Nutr Rev 2011; 70: 3–21.

    Google Scholar 

  182. 182

    Zhai F, Wang H, Wang Z, Popkin BM, Chen C . Closing the energy gap to prevent weight gain in China. Obes Rev 2008; 9 (Suppl 1): 107–112.

    PubMed  PubMed Central  Google Scholar 

  183. 183

    Akers JD, Estabrooks PA, Davy BM . Translational research: bridging the gap between long-term weight loss maintenance research and practice. J Am Diet Assoc 2010; 110: 1511–1522 1522.e1–1522.e3.

    PubMed  PubMed Central  Google Scholar 

  184. 184

    Anderson SE, Whitaker RC . Prevalence of obesity among US preschool children in different racial and ethnic groups. Arch Pediatr Adolesc Med 2009; 163: 344–348.

    PubMed  PubMed Central  Google Scholar 

  185. 185

    Anand SS, Yusuf S . Stemming the global tsunami of cardiovascular disease. Lancet 2011; 377: 529–532.

    PubMed  PubMed Central  Google Scholar 

  186. 186

    Leggio M, Mazza A, Cruciani G, Sgorbini L, Pugliese M, Bendini MG, Severi P, Jesi AP . Effects of exercise training on systo-diastolic ventricular dysfunction in patients with hypertension: an echocardiographic study with tissue velocity and strain imaging evaluation. Hypertens Res 2014; 37: 649–654.

    PubMed  PubMed Central  Google Scholar 

  187. 187

    Liu J, Sui X, Lavie CJ, Zhou H, Park YM, Cai B, Liu J, Blair SN . Effects of cardiorespiratory fitness on blood pressure trajectory with aging in a cohort of healthy men. J Am Coll Cardiol 2014; 64: 1245–1253.

    PubMed  PubMed Central  Google Scholar 

  188. 188

    Lavie CJ, McAuley PA, Church TS, Milani RV, Blair SN . Obesity and cardiovascular diseases: implications regarding fitness, fatness, and severity in the obesity paradox. J Am Coll Cardiol 2014; 63: 1345–1354.

    PubMed  PubMed Central  Google Scholar 

  189. 189

    Schwingshackl L, Dias S, Hoffmann G . Impact of long-term lifestyle programmes on weight loss and cardiovascular risk factors in overweight/obese participants: a systematic review and network meta-analysis. Syst Rev 2014; 3: 130.

    PubMed  PubMed Central  Google Scholar 

  190. 190

    Nurkkala M, Kaikkonen K, Vanhala ML, Karhunen L, Keränen AM, Korpelainen R . Lifestyle intervention has a beneficial effect on eating behavior and long-term weight loss in obese adults. Eat Behav 2015; 18: 179–185.

    PubMed  PubMed Central  Google Scholar 

  191. 191

    Newton RL, Griffith DM, Kearney WB, Bennett GG . A systematic review of weight loss, physical activity and dietary interventions involving African American men. Obes Rev 2014; 15: 93–106.

    PubMed  PubMed Central  Google Scholar 

  192. 192

    Clark JE . Diet, exercise or diet with exercise: comparing the effectiveness of treatment options for weight-loss and changes in fitness for adults (18-65 years old) who are overfat, or obese; systematic review and meta-analysis. J Diabetes Metab Disord 2015; 14: 31.

    PubMed  PubMed Central  Google Scholar 

  193. 193

    Ades PA, Savage PD, Harvey-Berino J . The treatment of obesity in cardiac rehabilitation. J Cardiopulm Rehabil Prev 2010; 30: 289–298.

    PubMed  PubMed Central  Google Scholar 

  194. 194

    Ades PA, Savage PD, Toth MJ, Harvey-Berino J, Schneider DJ, Bunn JY, Audelin MC, Ludlow M . High-calorie-expenditure exercise: a new approach to cardiac rehabilitation for overweight coronary patients. Circulation 2009; 119: 2671–2678.

    PubMed  PubMed Central  Google Scholar 

  195. 195

    Looney SM, Raynor HA . Behavioral lifestyle intervention in the treatment of obesity. Health Serv Insights 2013; 6: 15–31.

    PubMed  PubMed Central  Google Scholar 

  196. 196

    Ades PA . A lifestyle program of exercise and weight loss is effective in preventing and treating type 2 diabetes mellitus: why are programs not more available? Prev Med 2015; 80: 50–52.

    PubMed  PubMed Central  Google Scholar 

  197. 197

    Spahn JM, Reeves RS, Keim KS, Laquatra I, Kellogg M, Jortberg B, Clark NA . State of the evidence regarding behavior change theories and strategies in nutrition counseling to facilitate health and food behavior change. J Am Diet Assoc 2010; 110: 879–891.

    PubMed  PubMed Central  Google Scholar 

  198. 198

    Lucini D, Cesana G, Vigo C, Malacarne M, Pagani M . Reducing weight in an internal medicine outpatient clinic using a lifestyle medicine approach: a proof of concept. Eur J Intern Med 2015; 26: 680–684.

    PubMed  PubMed Central  Google Scholar 

  199. 199

    McNellis R, Lewis P 3rd . Behavioral counseling to promote a healthful diet and physical activity for cardiovascular disease prevention in adults with cardiovascular risk factors. Am Fam Physician 2015; 92: 509–510.

    PubMed  PubMed Central  Google Scholar 

  200. 200

    Voulgari C, Pagoni S, Vinik A, Poirier P . Exercise improves cardiac autonomic function in obesity and diabetes. Metabolism 2013; 62: 609–621.

    CAS  Google Scholar 

  201. 201

    de Jonge L, Moreira EA, Martin CK, Ravussin E, Pennington CALERIE Team. Impact of 6-month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals. Obesity (Silver Spring) 2010; 18: 414–416.

    Google Scholar 

  202. 202

    Hegde SM, Solomon SD . Influence of physical activity on hypertension and cardiac structure and function. Curr Hypertens Rep 2015; 17: 77.

    PubMed  PubMed Central  Google Scholar 

  203. 203

    Severi P, D’Emidio S, Armeni M, Bravi V, Leggio M . Exercise training and hypertension: ready for prime-time? Sports Med Rehabil J 2017; 2: 1011.

    Google Scholar 

  204. 204

    Swift DL, Johannsen NM, Lavie CJ, Earnest CP, Church TS . The role of exercise and physical activity in weight loss and maintenance. Prog Cardiovasc Dis 2014; 56: 441–447.

    Google Scholar 

  205. 205

    Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM . Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003; 42: 878–884.

    CAS  PubMed  PubMed Central  Google Scholar 

  206. 206

    Aucott L, Poobalan A, Smith WC, Avenell A, Jung R, Broom J . Effects of weight loss in overweight/obese individuals and long-term hypertension outcomes: a systematic review. Hypertension 2005; 45: 1035–1041.

    CAS  PubMed  PubMed Central  Google Scholar 

  207. 207

    Aucott L, Rothnie H, McIntyre L, Thapa M, Waweru C, Gray D . Long-term weight loss from lifestyle intervention benefits blood pressure?: a systematic review. Hypertension 2009; 54: 756–762.

    CAS  Google Scholar 

  208. 208

    Semlitsch T, Jeitler K, Berghold A, Horvath K, Posch N, Poggenburg S, Siebenhofer A . Long-term effects of weight-reducing diets in people with hypertension. Cochrane Database Syst Rev 2016; 3: CD008274.

    Google Scholar 

  209. 209

    Bray GA . Lifestyle and pharmacological approaches to weight loss: efficacy and safety. J Clin Endocrinol Metab 2008; 93 (Suppl 1): S81–S88.

    CAS  PubMed  PubMed Central  Google Scholar 

  210. 210

    Makris A, Foster GD . Dietary approaches to the treatment of obesity. Psychiatr Clin North Am 2011; 34: 813–827.

    PubMed  PubMed Central  Google Scholar 

  211. 211

    Avenell A, Broom J, Brown TJ, Poobalan A, Aucott L, Stearns SC, Smith WC, Jung RT, Campbell MK, Grant AM . Systematic review of the long-term effects and economic consequences of treatments for obesity and implications for health improvement. Health Technol Assess 2004; 8 iii–iv 1–182.

    Google Scholar 

  212. 212

    Nordmann AJ, Nordmann A, Briel M, Keller U, Yancy WS Jr, Brehm BJ, Bucher HC . Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 285–293.

    CAS  Google Scholar 

  213. 213

    Appel LJ . ASH position paper: dietary approaches to lower blood pressure. J Am Soc Hypertens 2009; 3: 321–331.

    PubMed  PubMed Central  Google Scholar 

  214. 214

    Appel LJ, Moore TJ, Obarzanek E, Vollmer WM, Svetkey LP, Sacks FM, Bray GA, Vogt TM, Cutler JA, Windhauser MM, Lin PH, Karanja N . A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. N Engl J Med 1997; 336: 1117–1124.

    CAS  Google Scholar 

  215. 215

    Kastorini CM, Milionis HJ, Esposito K, Giugliano D, Goudevenos JA, Panagiotakos DB . The effect of Mediterranean diet on metabolic syndrome and its components: a meta-analysis of 50 studies and 534,906 individuals. J Am Coll Cardiol 2011; 57: 1299–1313.

    CAS  PubMed  PubMed Central  Google Scholar 

  216. 216

    Beilin LJ, Burke V . Vegetarian diet components, protein and blood pressure: which nutrients are important? Clin Exp Pharmacol Physiol 1995; 22: 195–198.

    CAS  Google Scholar 

  217. 217

    Miller ER 3rd, Erlinger TP, Young DR, Jehn M, Charleston J, Rhodes D, Wasan SK, Appel LJ . Results of the Diet, Exercise, and Weight Loss Intervention Trial (DEW-IT). Hypertension 2002; 40: 612–618.

    CAS  PubMed  PubMed Central  Google Scholar 

  218. 218

    Elmer PJ, Obarzanek E, Vollmer WM, Simons-Morton D, Stevens VJ, Young DR, Lin PH, Champagne C, Harsha DW, Svetkey LP, Ard J, Brantley PJ, Proschan MA, Erlinger TP, Appel LJ, PREMIER Collaborative Research Group. Effects of comprehensive lifestyle modification on diet, weight, physical fitness, and blood pressure control: 18-month results of a randomized trial. Ann Intern Med 2006; 144: 485–495.

    Google Scholar 

  219. 219

    Jehn ML, Patt MR, Appel LJ, Miller ER 3rd . One year follow-up of overweight and obese hypertensive adults following intensive lifestyle therapy. J Hum Nutr Diet 2006; 19: 349–354.

    CAS  PubMed  PubMed Central  Google Scholar 

  220. 220

    Lien LF, Brown AJ, Ard JD, Loria C, Erlinger TP, Feldstein AC, Lin PH, Champagne CM, King AC, McGuire HL, Stevens VJ, Brantley PJ, Harsha DW, McBurnie MA, Appel LJ, Svetkey LP . Effects of PREMIER lifestyle modifications on participants with and without the metabolic syndrome. Hypertension 2007; 50: 609–616.

    CAS  Google Scholar 

  221. 221

    Blumenthal JA, Babyak MA, Hinderliter A, Watkins LL, Craighead L, Lin PH, Caccia C, Johnson J, Waugh R, Sherwood A . Effects of the DASH diet alone and in combination with exercise and weight loss on blood pressure and cardiovascular biomarkers in men and women with high blood pressure: the ENCORE study. Arch Intern Med 2010; 170: 126–135.

    PubMed  PubMed Central  Google Scholar 

  222. 222

    Gao SK, Fitzpatrick AL, Psaty B, Jiang R, Post W, Cutler J, Maciejewski ML . Suboptimal nutritional intake for hypertension control in 4 ethnic groups. Arch Intern Med 2009; 169: 702–707.

    CAS  Google Scholar 

  223. 223

    Burke V, Beilin LJ, Cutt HE, Mansour J, Wilson A, Mori TA . Effects of a lifestyle programme on ambulatory blood pressure and drug dosage in treated hypertensive patients: a randomized controlled trial. J Hypertens 2005; 23: 1241–1249.

    CAS  Google Scholar 

  224. 224

    Sacks FM, Svetkey LP, Vollmer WM, Appel LJ, Bray GA, Harsha D, Obarzanek E, Conlin PR, Miller ER 3rd, Simons-Morton DG, Karanja N, Lin PH, DASH-Sodium Collaborative Research Group. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med 2001; 344: 3–10.

    CAS  Google Scholar 

  225. 225

    Fujita T . Mineralocorticoid receptors, salt-sensitive hypertension, and metabolic syndrome. Hypertension 2010; 55: 813–818.

    CAS  PubMed  PubMed Central  Google Scholar 

  226. 226

    Cook NR, Cutler JA, Obarzanek E, Buring JE, Rexrode KM, Kumanyika SK, Appel LJ, Whelton PK . Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP). BMJ 2007; 334: 885–888.

    PubMed  PubMed Central  Google Scholar 

  227. 227

    The Hypertension Prevention Trial: three-year effects of dietary changes on blood pressure. Hypertension Prevention Trial Research Group. Arch Intern Med 1990; 150: 153–162.

  228. 228

    Whelton PK, Kumanyika SK, Cook NR, Cutler JA, Borhani NO, Hennekens CH, Kuller LH, Langford H, Jones DW, Satterfield S, Lasser NL, Cohen JD . Efficacy of nonpharmacologic interventions in adults with high-normal blood pressure: results from phase 1 of the Trials of Hypertension Prevention. Trials of Hypertension Prevention Collaborative Research Group. Am J Clin Nutr 1997; 65 (2 Suppl): 652S–660S.

    CAS  Google Scholar 

  229. 229

    Stevens VJ, Obarzanek E, Cook NR, Lee IM, Appel LJ, Smith West D, Milas NC, Mattfeldt-Beman M, Belden L, Bragg C, Millstone M, Raczynski J, Brewer A, Singh B, Cohen J, Trials for the Hypertension Prevention Research Group. Long-term weight loss and changes in blood pressure: results of the Trials of Hypertension Prevention, phase II. Ann Intern Med 2001; 134: 1–11.

    CAS  Google Scholar 

  230. 230

    Kumanyika SK, Cook NR, Cutler JA, Belden L, Brewer A, Cohen JD, Hebert PR, Lasser VI, Raines J, Raczynski J, Shepek L, Diller L, Whelton PK, Yamamoto M, Trials of Hypertension Prevention Collaborative Research Group. Sodium reduction for hypertension prevention in overweight adults: further results from the Trials of Hypertension Prevention Phase II. J Hum Hypertens 2005; 19: 33–45.

    CAS  Google Scholar 

  231. 231

    Appel LJ, Espeland MA, Easter L, Wilson AC, Folmar S, Lacy CR . Effects of reduced sodium intake on hypertension control in older individuals: results from the Trial of Nonpharmacologic Interventions in the Elderly (TONE). Arch Intern Med 2001; 161: 685–693.

    CAS  Google Scholar 

  232. 232

    Thorogood A, Mottillo S, Shimony A, Filion KB, Joseph L, Genest J, Pilote L, Poirier P, Schiffrin EL, Eisenberg MJ . Isolated aerobic exercise and weight loss: a systematic review and meta-analysis of randomized controlled trials. Am J Med 2011; 124: 747–755.

    Google Scholar 

  233. 233

    Douketis JD, Macie C, Thabane L, Williamson DF . Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice. Int J Obes (Lond) 2005; 29: 1153–1167.

    CAS  Google Scholar 

  234. 234

    Fagard RH . Exercise is good for your blood pressure: effects of endurance training and resistance training. Clin Exp Pharmacol Physiol 2006; 33: 853–856.

    CAS  Google Scholar 

  235. 235

    Cox KL, Puddey IB, Morton AR, Burke V, Beilin LJ, McAleer M . Exercise and weight control in sedentary overweight men: effects on clinic and ambulatory blood pressure. J Hypertens 1996; 14: 779–790.

    CAS  Google Scholar 

  236. 236

    Cornelissen VA, Fagard RH, Coeckelberghs E, Vanhees L . Impact of resistance training on blood pressure and other cardiovascular risk factors: a meta-analysis of randomized, controlled trials. Hypertension 2011; 58: 950–958.

    CAS  PubMed  PubMed Central  Google Scholar 

  237. 237

    Shaw K, Gennat H, O'Rourke P, Del Mar C . Exercise for overweight or obesity. Cochrane Database Syst Rev 2006; (4: CD003817.

    Google Scholar 

  238. 238

    Fogelholm M, Kukkonen-Harjula K . Does physical activity prevent weight gain—a systematic review. Obes Rev 2000; 1: 95–111.

    CAS  Google Scholar 

  239. 239

    Jakicic JM . The effect of physical activity on body weight. Obesity (Silver Spring) 2009; 17 (Suppl 3): S34–S38.

    Google Scholar 

  240. 240

    Proper KI, Singh AS, van Mechelen W, Chinapaw MJ . Sedentary behaviors and health outcomes among adults: a systematic review of prospective studies. Am J Prev Med 2011; 40: 174–182.

    Google Scholar 

  241. 241

    Whitman IR, Agarwal V, Nah G, Dukes JW, Vittinghoff E, Dewland TA, Marcus GM . Alcohol abuse and cardiac disease. J Am Coll Cardiol 2017; 69: 13–24.

    CAS  PubMed  PubMed Central  Google Scholar 

  242. 242

    Puddey IB, Beilin LJ . Alcohol is bad for blood pressure. Clin Exp Pharmacol Physiol 2006; 33: 847–852.

    CAS  Google Scholar 

  243. 243

    Sayon-Orea C, Martinez-Gonzalez MA, Bes-Rastrollo M . Alcohol consumption and body weight: a systematic review. Nutr Rev 2011; 69: 419–431.

    Google Scholar 

  244. 244

    Puddey IB, Parker M, Beilin LJ, Vandongen R, Masarei JR . Effects of alcohol and caloric restrictions on blood pressure and serum lipids in overweight men. Hypertension 1992; 20: 533–541.

    CAS  Google Scholar 

  245. 245

    Canoy D, Wareham N, Luben R, Welch A, Bingham S, Day N, Khaw KT . Cigarette smoking and fat distribution in 21,828 British men and women: a population-based study. Obes Res 2005; 13: 1466–1475.

    Google Scholar 

  246. 246

    Rhee MY, Na SH, Kim YK, Lee MM, Kim HY . Acute effects of cigarette smoking on arterial stiffness and blood pressure in male smokers with hypertension. Am J Hypertens 2007; 20: 637–641.

    CAS  Google Scholar 

  247. 247

    Simpson SA, Shaw C, McNamara R . What is the most effective way to maintain weight loss in adults? BMJ 2011; 343: d8042.

    Google Scholar 

  248. 248

    Van Dorsten B, Lindley EM . Cognitive and behavioral approaches in the treatment of obesity. Med Clin North Am 2011; 95: 971–988.

    Google Scholar 

  249. 249

    Greaves CJ, Sheppard KE, Abraham C, Hardeman W, Roden M, Evans PH, Schwarz P, IMAGE Study Group. Systematic review of reviews of intervention components associated with increased effectiveness in dietary and physical activity interventions. BMC Public Health 2011; 11: 119.

    PubMed  PubMed Central  Google Scholar 

  250. 250

    Svetkey LP, Stevens VJ, Brantley PJ, Appel LJ, Hollis JF, Loria CM, Vollmer WM, Gullion CM, Funk K, Smith P, Samuel-Hodge C, Myers V, Lien LF, Laferriere D, Kennedy B, Jerome GJ, Heinith F, Harsha DW, Evans P, Erlinger TP, Dalcin AT, Coughlin J, Charleston J, Champagne CM, Bauck A, Ard JD, Aicher K, Weight Loss Maintenance Collaborative Research Group. Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial. JAMA 2008; 299: 1139–1148.

    CAS  Google Scholar 

  251. 251

    Funk KL, Stevens VJ, Appel LJ, Bauck A, Brantley PJ, Champagne CM, Coughlin J, Dalcin AT, Harvey-Berino J, Hollis JF, Jerome GJ, Kennedy BM, Lien LF, Myers VH, Samuel-Hodge C, Svetkey LP, Vollmer WM . Associations of internet website use with weight change in a long-term weight loss maintenance program. J Med Internet Res 2010; 12: e29.

    PubMed  PubMed Central  Google Scholar 

  252. 252

    Tham JC, le Roux CW, Docherty NG . Cardiovascular, renal and overall health outcomes after bariatric surgery. Curr Cardiol Rep 2015; 17: 34.

    Google Scholar 

  253. 253

    Colquitt JL, Pickett K, Loveman E, Frampton GK . Surgery for weight loss in adults. Cochrane Database Syst Rev 2014; 8: CD003641.

    Google Scholar 

  254. 254

    Petersen KS, Blanch N, Keogh JB, Clifton PM . Effect of weight loss on pulse wave velocity: systematic review and meta-analysis. Arterioscler Thromb Vasc Biol 2015; 35: 243–252.

    CAS  Google Scholar 

  255. 255

    Boido A, Ceriani V, Cetta F, Lombardi F, Pontiroli AE . Bariatric surgery and prevention of cardiovascular events and mortality in morbid obesity: mechanisms of action and choice of surgery. Nutr Metab Cardiovasc Dis 2015; 25: 437–443.

    CAS  Google Scholar 

  256. 256

    de Jonge L, Moreira EA, Martin CK, Ravussin E, Pennington CALERIE Team. Impact of 6-month caloric restriction on autonomic nervous system activity in healthy, overweight, individuals. Obesity (Silver Spring) 2010; 18: 414–416.

    Google Scholar 

  257. 257

    Jassil FC, Manning S, Lewis N, Steinmo S, Kingett H, Lough F, Pucci AB, Cheung WH, Finer N, Walker J, Doyle J, Batterham RL . Feasibility and impact of a combined supervised exercise and nutritional-behavioral intervention following bariatric surgery: a pilot study. J Obes 2015; 2015: 693829.

    PubMed  PubMed Central  Google Scholar 

  258. 258

    Kushner RF . Weight loss strategies for treatment of obesity. Prog Cardiovasc Dis 2014; 56: 465–472.

    Google Scholar 

  259. 259

    Coen PM, Goodpaster BH . A role for exercise after bariatric surgery? Diabetes Obes Metab 2015; 18: 16–23.

    PubMed  PubMed Central  Google Scholar 

  260. 260

    Arena R, Lavie CJ . The healthy lifestyle team is central to the success of accountable care organizations. Mayo Clin Proc 2015; 90: 572–576.

    Google Scholar 

  261. 261

    Butsch WS . Obesity medications: what does the future look like? Curr Opin Endocrinol Diabetes Obes 2015; 22: 360–366.

    CAS  PubMed  PubMed Central  Google Scholar 

  262. 262

    Lavie CJ, Milani RV, Ventura HO . Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss. J Am Coll Cardiol 2009; 53: 1925–1932.

    Google Scholar 

  263. 263

    Lavie CJ, Milani RV, O’Keefe JH . The Russert impact: a golden opportunity to promote primary coronary prevention. Ochsner J 2008; 8: 108–113.

    PubMed  PubMed Central  Google Scholar 

  264. 264

    Artham SM, Lavie CJ, Milani RV, Patel DA, Verma A, Ventura HO . Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis 2009; 52: 153–167.

    Google Scholar 

  265. 265

    Lavie CJ, Patel DA, Milani RV, Ventura HO, Shah S, Gilliland Y . Impact of echocardiographic left ventricular geometry on clinical prognosis. Prog Cardiovasc Dis 2014; 57: 3–9.

    Google Scholar 

  266. 266

    DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D'Ascenzo F, Cerrato E, Biondi-Zoccai G, Lavie CJ, Bell DS, O'Keefe JH . β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart 2015; 2: e000230.

    PubMed  PubMed Central  Google Scholar 

  267. 267

    Marcus JA, Pothineni A, Marcus CZ, Bisognano JD . The role of obesity and obstructive sleep apnea in the pathogenesis and treatment of resistant hypertension. Curr Hypertens Rep 2014; 16: 411.

    Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Massimo Leggio.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Leggio, M., Lombardi, M., Caldarone, E. et al. The relationship between obesity and hypertension: an updated comprehensive overview on vicious twins. Hypertens Res 40, 947–963 (2017). https://doi.org/10.1038/hr.2017.75

Download citation

Keywords

  • cardiovascular risk
  • obesity

Further reading

Search

Quick links